Bempedoic Acid

Overview

Bempedoic acid is an ATP-citrate lyase inhibitor used as a therapeutic option for lowering low-density lipoprotein cholesterol (LDL-C) levels in adults with hypercholesterolemia. It is often used in combination with other lipid-lowering medications to achieve cholesterol targets.

API suppliers (3)

Suppliers of Bempedoic Acid backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MICRO LABS LTDIndia1 active DMF
• MICRO LABS LTDIndia1 active DMF
• MICRO LABS LTDIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Bempedoic Acid expires 18 Jun 2040 and exclusivity 22 Mar 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas